Your browser doesn't support javascript.
loading
Evolutionary and functional history of the Escherichia coli K1 capsule.
Arredondo-Alonso, Sergio; Blundell-Hunter, George; Fu, Zuyi; Gladstone, Rebecca A; Fillol-Salom, Alfred; Loraine, Jessica; Cloutman-Green, Elaine; Johnsen, Pål J; Samuelsen, Ørjan; Pöntinen, Anna K; Cléon, François; Chavez-Bueno, Susana; De la Cruz, Miguel A; Ares, Miguel A; Vongsouvath, Manivanh; Chmielarczyk, Agnieszka; Horner, Carolyne; Klein, Nigel; McNally, Alan; Reis, Joice N; Penadés, José R; Thomson, Nicholas R; Corander, Jukka; Taylor, Peter W; McCarthy, Alex J.
Affiliation
  • Arredondo-Alonso S; Department of Biostatistics, University of Oslo, 0317, Oslo, Norway.
  • Blundell-Hunter G; Parasites and Microbes, Wellcome Sanger Institute, Cambridge, UK.
  • Fu Z; School of Pharmacy, University College London, London, UK.
  • Gladstone RA; Department of Infectious Disease, Centre for Bacterial Resistance Biology, Imperial College London, London, UK.
  • Fillol-Salom A; Department of Biostatistics, University of Oslo, 0317, Oslo, Norway.
  • Loraine J; Parasites and Microbes, Wellcome Sanger Institute, Cambridge, UK.
  • Cloutman-Green E; Department of Infectious Disease, Centre for Bacterial Resistance Biology, Imperial College London, London, UK.
  • Johnsen PJ; School of Pharmacy, University College London, London, UK.
  • Samuelsen Ø; Great Ormond Street Institute of Child Health, University College London, London, UK.
  • Pöntinen AK; Department of Pharmacy, Faculty of Health Sciences, UiT The Arctic University of Norway, Tromsø, Norway.
  • Cléon F; Department of Pharmacy, Faculty of Health Sciences, UiT The Arctic University of Norway, Tromsø, Norway.
  • Chavez-Bueno S; Norwegian National Advisory Unit on Detection of Antimicrobial Resistance, Department of Microbiology and Infection Control, University Hospital of North Norway, Tromsø, Norway.
  • De la Cruz MA; Department of Biostatistics, University of Oslo, 0317, Oslo, Norway.
  • Ares MA; Norwegian National Advisory Unit on Detection of Antimicrobial Resistance, Department of Microbiology and Infection Control, University Hospital of North Norway, Tromsø, Norway.
  • Vongsouvath M; Department of Pharmacy, Faculty of Health Sciences, UiT The Arctic University of Norway, Tromsø, Norway.
  • Chmielarczyk A; University of Missouri Kansas City, Kansas City, USA.
  • Horner C; Division of Infectious Diseases, Children's Mercy Hospital Kansas City, UMKC School of Medicine, Kansas City, USA.
  • Klein N; Unidad de Investigación Médica en Enfermedades Infecciosas y Parasitarias, Hospital de Pediatría, Centro Médico Nacional Siglo XXI Instituto Mexicano del Seguro Social, Mexico City, Mexico.
  • McNally A; Facultad de Medicina, Benemérita Universidad Autónoma de Puebla, Puebla, Mexico.
  • Reis JN; Unidad de Investigación Médica en Enfermedades Infecciosas y Parasitarias, Hospital de Pediatría, Centro Médico Nacional Siglo XXI Instituto Mexicano del Seguro Social, Mexico City, Mexico.
  • Penadés JR; Lao-Oxford-Mahosot Hospital-Wellcome Trust Research Unit (LOMWRU), Microbiology Laboratory, Mahosot Hospital, Vientiane, Lao PDR.
  • Thomson NR; Faculty of Medicine, Chair of Microbiology, Jagiellonian University Medical College, Czysta str. 18, 31-121, Kraków, Poland.
  • Corander J; British Society for Antimicrobial Chemotherapy, Birmingham, UK.
  • Taylor PW; Great Ormond Street Institute of Child Health, University College London, London, UK.
  • McCarthy AJ; Institute of Microbiology and Infection, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.
Nat Commun ; 14(1): 3294, 2023 06 15.
Article de En | MEDLINE | ID: mdl-37322051
ABSTRACT
Escherichia coli is a leading cause of invasive bacterial infections in humans. Capsule polysaccharide has an important role in bacterial pathogenesis, and the K1 capsule has been firmly established as one of the most potent capsule types in E. coli through its association with severe infections. However, little is known about its distribution, evolution and functions across the E. coli phylogeny, which is fundamental to elucidating its role in the expansion of successful lineages. Using systematic surveys of invasive E. coli isolates, we show that the K1-cps locus is present in a quarter of bloodstream infection isolates and has emerged in at least four different extraintestinal pathogenic E. coli (ExPEC) phylogroups independently in the last 500 years. Phenotypic assessment demonstrates that K1 capsule synthesis enhances E. coli survival in human serum independent of genetic background, and that therapeutic targeting of the K1 capsule re-sensitizes E. coli from distinct genetic backgrounds to human serum. Our study highlights that assessing the evolutionary and functional properties of bacterial virulence factors at population levels is important to better monitor and predict the emergence of virulent clones, and to also inform therapies and preventive medicine to effectively control bacterial infections whilst significantly lowering antibiotic usage.
Sujet(s)

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Protéines Escherichia coli / Infections à Escherichia coli Type d'étude: Prognostic_studies Limites: Humans Langue: En Journal: Nat Commun Sujet du journal: BIOLOGIA / CIENCIA Année: 2023 Type de document: Article Pays d'affiliation: Norvège

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Protéines Escherichia coli / Infections à Escherichia coli Type d'étude: Prognostic_studies Limites: Humans Langue: En Journal: Nat Commun Sujet du journal: BIOLOGIA / CIENCIA Année: 2023 Type de document: Article Pays d'affiliation: Norvège
...